Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75,607,738
-
Total 13F shares
-
42,788,014
-
Share change
-
+5,591,061
-
Total reported value
-
$3,103,439,098
-
Price per share
-
$72.52
-
Number of holders
-
120
-
Value change
-
+$398,643,892
-
Number of buys
-
90
-
Number of sells
-
21
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q4 2020
As of 31 Dec 2020,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,788,014 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, FMR LLC, BlackRock Inc., BOXER CAPITAL, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ArrowMark Colorado Holdings LLC, VANGUARD GROUP INC, and DRIEHAUS CAPITAL MANAGEMENT LLC.
This page lists
121
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.